These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

537 related items for PubMed ID: 15513292

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
    Burger H.
    Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hormone therapy in the WHI era.
    Burger HG.
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):84-91. PubMed ID: 16638027
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Postmenopausal hormone replacement therapy and the prevention of cardiovascular disease: a review.
    Abramson BL.
    J Cardiovasc Risk; 2002 Dec; 9(6):309-14. PubMed ID: 12478199
    [Abstract] [Full Text] [Related]

  • 8. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
    Kuhl H, Stevenson J.
    Gynecol Endocrinol; 2006 Jun; 22(6):303-17. PubMed ID: 16785155
    [Abstract] [Full Text] [Related]

  • 9. A comparative review of the risks and benefits of hormone replacement therapy regimens.
    Warren MP.
    Am J Obstet Gynecol; 2004 Apr; 190(4):1141-67. PubMed ID: 15118656
    [Abstract] [Full Text] [Related]

  • 10. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Bittner V.
    Expert Opin Pharmacother; 2009 Sep; 10(13):2041-53. PubMed ID: 19563274
    [Abstract] [Full Text] [Related]

  • 11. Health risks after cessation of postmenopausal hormone therapy.
    Pines A, Sturdee D, Birkhäuser M, International Menopause Society.
    Climacteric; 2008 Jun; 11(3):179-80. PubMed ID: 18568782
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Women's awareness and knowledge of hormone therapy post-Women's Health Initiative.
    Rigby AJ, Ma J, Stafford RS.
    Menopause; 2007 Jun; 14(5):853-8. PubMed ID: 17429334
    [Abstract] [Full Text] [Related]

  • 15. Benefits and challenges of hormone replacement therapy.
    Borgelt L, Umland E.
    J Am Pharm Assoc (Wash); 2000 Jun; 40(5 Suppl 1):S30-1. PubMed ID: 11029858
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Menopausal hormone replacement therapy.
    Varner RE.
    Curr Womens Health Rep; 2003 Oct; 3(5):410-7. PubMed ID: 12959701
    [Abstract] [Full Text] [Related]

  • 18. Hormone replacement therapy in postmenopausal women.
    Prelevic GM, Kocjan T, Markou A.
    Minerva Endocrinol; 2005 Mar; 30(1):27-36. PubMed ID: 15877011
    [Abstract] [Full Text] [Related]

  • 19. Lessons learned from the WHI: HRT requires a cautious and individualized approach.
    Aubuchon M, Santoro N.
    Geriatrics; 2004 Nov; 59(11):22-6. PubMed ID: 15615157
    [Abstract] [Full Text] [Related]

  • 20. Implications of recent clinical trials of postmenopausal hormone therapy for management of cardiovascular disease.
    Rossouw JE.
    Ann N Y Acad Sci; 2006 Nov; 1089():444-53. PubMed ID: 17261787
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.